在停止服用SSRI后,5-HT神经元的反弹激活
Helen M Collins1,2, L Sophie Gullino1, Dersu Ozdemir1
1Dept. of Pharmacology, University of Oxford, Oxford, UK.
概括
停止选择性血清素再吸收抑制剂 (SSRI),如帕洛克,会导致血清素 (5-HT) 神经元活动的反弹,导致类似焦虑的行为. 这项研究调查了SSRI停药综合征背后的神经化学变化.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 选择性血清素再吸收抑制剂 (SSRI) 是广泛处方的抗抑郁药.
- 突然停止SSRI治疗可以诱导一种停药综合征,其机制尚不清楚.
- 血清素 (5-HT) 神经传递对情绪调节至关重要,是SSRI的目标.
研究的目的:
- 在小鼠中研究停止帕洛克塞丁治疗对血清素系统的神经化学和功能影响.
- 探索SSRI停药综合征的潜在机制.
- 为了将神经化学变化与行为结果相关联.
主要方法:
- 对小鼠进行重复给予帕洛克塞丁,然后继续治疗或停止治疗.
- 对5-HT及其代谢物5-HIAA的大脑组织水平的测量.
- 在体内微透析以评估细胞外5-HT和引起释放.
- 免疫组织化学检测神经元激活 (c-Fos表达).
- 行为测试来测量类似焦虑的行为.
主要成果:
- 停止服用帕洛西丁导致大脑组织,特别是海马体中的5-HT和5-HIAA水平增加.
- 停止治疗逆转了帕洛克对细胞外5-HT和唤起释放的影响,表明过度兴奋.
- 在中脑5-HT神经元中增加的c-Fos表达在停药后被观察到.
- 在小鼠中,停用帕洛西丁诱导了类似焦虑的行为,与增加的5-HT系统活性相关.
结论:
- 停止服用SSRI会触发血清激素系统的反弹激活.
- 这种反弹过度兴奋可能会导致戒断综合征的症状.
- 这些发现表明,一种共同的神经生物学机制是各种精神药物戒断的基础.
相关概念视频
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
380
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
380
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
249
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
249
Antidepressant Drugs: MAOIs and Other Agents
227
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
227
Desensitization and Tachyphylaxis
1.7K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.7K
G-protein Coupled Receptors
118.6K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
118.6K
Drugs Affecting Neurotransmitter Release or Uptake
1.0K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.0K


